Elfin Drugs Private Limited - Company Profile

It is a pharma private limited company based in Mohali, Punjab, India, established in 2005.
2005 Mohali, Punjab, India Active
Last Updated:
Access Report
About Elfin Drugs Private Limited

Elfin Drugs Private Limited, a active private limited company, was established on 25 April 2005 in Mohali, Punjab, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231PB2005PTC028300. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.05 M.

It upholds a compliant status. Employing 19 professional, Its leadership includes Dilpreet Singh (Director), Surinder Jit Kaur (Director). Past directors included Shashi Kumar Sahai, Gurinder Kaur Makkar, Manpreet Kaur. It holds ₹20.42 Cr open charges and ₹18.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-206, Industrial Area, Phase-8-B, Mohali, Punjab, 160055.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231PB2005PTC028300

  • Registration Number

    028300

  • Incorporation Date

    25 April 2005

  • Authorized Capital

    ₹7.50 M

  • Paid-Up Capital

    ₹7.05 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.50 M
  • Paid Up Capital ₹ 7.05 M
  • Company Age 20 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 20.42 Cr
  • Satisfied Charges ₹ 18.50 Cr
  • Revenue Growth **** 14.98%
  • Profit Growth **** 20.89%
  • Ebitda **** 26.04%
  • Net Worth 5.96%
  • Total Assets **** 4.30%
Company report

Elfin Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Elfin Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Elfin Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Dilpreet Singh Director 25 Apr 2005 Current
Surinder Jit Kaur Director 19 Jun 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 25 Oct 2012 Past
Pramod Abcsdd Director 25 Jun 2020 Past
Pramod Abcsdd Director 25 Jun 2020 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Additional Director 30 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elfin Drugs.

Elfin Drugs Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.98% increase. The company also saw a substantial improvement in profitability, with a 20.89% increase in profit. The company's net worth moved up by a moderate rise of 5.96%.

Elfin Drugs revenue growth over time
Elfin Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 14.98%
*******
*******
*******
*******
Revenue from Operations
*******
 14.78%
*******
*******
*******
*******
Total Assets
*******
 4.30%
*******
*******
*******
*******
Profit or Loss
*******
 20.89%
*******
*******
*******
*******
Net Worth
*******
 5.96%
*******
*******
*******
*******
EBITDA
*******
 26.04%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elfin Drugs?

In 2024, Elfin Drugs had a public holding of 5.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹204,181,338.00

Satisfied Charges

₹185,010,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 13.09 Cr
  • Oriental Bank Of Commerce : 7.01 Cr
  • Hdfc Bank Limited : 0.24 Cr
  • Others : 0.07 Cr
Latest Charge Details
Date Lender Amount Status
18 Apr 2024 Bank Of India ₹13.09 Cr Open
04 Nov 2022 Hdfc Bank Limited ₹1.55 M Open
26 Mar 2021 Hdfc Bank Limited ₹0.90 M Open
01 Feb 2018 Others ₹0.70 M Open
18 Jan 2008 Oriental Bank Of Commerce ₹5.54 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Elfin Drugs?

Elfin Drugs has a workforce of 19 employees as of Mar 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elfin Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elfin Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elfin Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Elfin Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Charges

    The activity A charge with Bank Of India of Rs. 130.93 M registered on 18 Apr 2024 with Charge ID 100900204 was modified on 08 Aug 2024. was completed.

  • Charges

    The activity A charge with Bank Of India amounted to Rs. 130.93 M with Charge ID 100900204 was registered on 18 Apr 2024. was completed.

  • Balance Sheet

    The activity Elfin Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.

  • Charges

    A charge registered on 04 Sep 2021 via Charge ID 100498253 with Hdfc Bank Limited was fully satisfied on 01 Feb 2024. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 104.61 M registered on 04 Sep 2021 with Charge ID 100498253 was modified on 01 May 2023. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Elfin Drugs Private Limited?

The CIN of Elfin Drugs Private Limited is U24231PB2005PTC028300.

Where is Elfin Drugs Private Limited headquartered?

Elfin Drugs Private Limited is headquartered at E-206, Industrial Area, Phase-8-B, Mohali, Punjab, 160055.

When was Elfin Drugs Private Limited incorporated?

Elfin Drugs Private Limited was incorporated on 25 April 2005.

Who are the current directors of Elfin Drugs Private Limited?

The current directors of Elfin Drugs Private Limited are

What is the primary industry of Elfin Drugs Private Limited?

The primary industry of Elfin Drugs Private Limited is Manufacturing.

Is Elfin Drugs Private Limited a listed company?

Elfin Drugs Private Limited is unlisted.

What is the capital structure of Elfin Drugs Private Limited?

The authorized capital of Elfin Drugs Private Limited is ₹7.50 M, and the paid-up capital is ₹7.05 M.

What is the compliance status of Elfin Drugs Private Limited?

The compliance status of Elfin Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available